Gene · 92521
Papers3,158
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 3,158
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comparative whole genome analysis reveals re-emergence of human Wa-like and DS-1-like G3 rotaviruses after Rotarix vaccine introduction in Malawi. | Virus Evol | 2023 | 37305707 | PubTator, text mining | PubMed |
Docking-Based Evidence for the Potential of ImmunoDefender: A Novel Formulated Essential Oil Blend Incorporating Synergistic Antiviral Bioactive Compounds as Promising Mpro Inhibitors against SARS-CoV-2. | Molecules | 2023 | 37298772 | PubTator, text mining | PubMed |
| Evaluation of the Antiviral Efficacy of Subcutaneous Nafamostat Formulated with Glycyrrhizic Acid against SARS-CoV-2 in a Murine Model. | Int J Mol Sci | 2023 | 37298530 | PubTator, text mining | PubMed |
| SARS-CoV-2 Evasion of the Interferon System: Can We Restore Its Effectiveness? | Int J Mol Sci | 2023 | 37298304 | PubTator, text mining | PubMed |
| Integration site-dependent HIV-1 promoter activity shapes host chromatin conformation. | Genome Res | 2023 | 37295842 | PubTator, text mining | PubMed |
| Elucidation of novel compounds and epitope-based peptide vaccine design against C30 endopeptidase regions of SARS-CoV-2 using immunoinformatics approaches. | Front Cell Infect Microbiol | 2023 | 37293206 | PubTator, text mining | PubMed |
| Host-specific sensing of coronaviruses and picornaviruses by the CARD8 inflammasome. | PLoS Biol | 2023 | 37289745 | PubTator, text mining | PubMed |
| Generation of SARS-CoV-2 escape mutations by monoclonal antibody therapy. | Nat Commun | 2023 | 37286554 | PubTator, text mining | PubMed |
| Interspecies transmission of porcine-originated G4P[6] rotavirus A between pigs and humans: a synchronized spatiotemporal approach. | Front Microbiol | 2023 | 37283926 | PubTator, text mining | PubMed |
| Swine acute diarrhoea syndrome coronavirus (SADS-CoV) Nsp5 antagonizes type I interferon signaling by cleaving DCP1A. | Front Immunol | 2023 | 37283741 | PubTator, text mining | PubMed |
| Mapping human norovirus antigens during infection reveals the breadth of the humoral immune response. | NPJ Vaccines | 2023 | 37280322 | PubTator, text mining | PubMed |
| Ebselen derivatives inhibit SARS-CoV-2 replication by inhibition of its essential proteins: PLpro and Mpro proteases, and nsp14 guanine N7-methyltransferase. | Sci Rep | 2023 | 37280236 | PubTator, text mining | PubMed |
| Contribution of the catalytic dyad of SARS-CoV-2 main protease to binding covalent and noncovalent inhibitors. | J Biol Chem | 2023 | 37271339 | PubTator, text mining | PubMed |
| Reinfection by SARS-CoV-2 by divergent Omicron sublineages, 16 days apart. | Braz J Microbiol | 2023 | 37269428 | PubTator, text mining | PubMed |
| Acute rotavirus infection is associated with the induction of circulating memory CD4+ T cell subsets. | Sci Rep | 2023 | 37268634 | PubTator, text mining | PubMed |
[Variability of genes encoding nonstructural proteins of rotavirus А (Reoviridae: Rotavirus: Rotavirus A) genotype G9P[8] during the period of dominance in the territory of Nizhny Novgorod (central part of Russia) (2011-2020)]. | Vopr Virusol | 2023 | 37264837 | PubTator, text mining | PubMed |
| Molecular transition of SARS-CoV-2 from critical patients during the first year of the COVID-19 pandemic in Mexico City. | Front Cell Infect Microbiol | 2023 | 37260697 | PubTator, text mining | PubMed |
| Discovery of quinazolin-4-one-based non-covalent inhibitors targeting the severe acute respiratory syndrome coronavirus 2 main protease (SARS-CoV-2 Mpro). | Eur J Med Chem | 2023 | 37257212 | PubTator, text mining | PubMed |
| Molecular mechanisms and cellular functions of liquid-liquid phase separation during antiviral immune responses. | Front Immunol | 2023 | 37251408 | PubTator, text mining | PubMed |
| Inflammasomes: a rising star on the horizon of COVID-19 pathophysiology. | Front Immunol | 2023 | 37251383 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/92521/papers?page=20